Compare Cassava Sciences Inc (FLNA) vs TechnipFMC plc Ordinary Share (FTI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs TechnipFMC plc Ordinary Share — how do they compare? Cassava Sciences Inc trades at $0.81 (market cap $39.40M), while TechnipFMC plc Ordinary Share trades at $69.75 (market cap $27.31B). The key difference: TechnipFMC plc Ordinary Share is far larger — about 693.1× Cassava Sciences Inc's market cap, and TechnipFMC plc Ordinary Share pays a 0.29% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 37 Days and TechnipFMC plc Ordinary Share for 0 Days on average.
| FLNA | FTI | |
|---|---|---|
Market Cap | $39.40M | $27.31B |
Volume | 759,018 | 2,496,410 |
Sector | Health | Energy |
52-Week High | $4.64 | $80.08 |
52-Week Low | $0.68 | $35.57 |
Typical Hold Time | 37 Days | 0 Days |
Enterprise Value | -$43.28M | $27.56B |
Dividend Yield | — | 0.29% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Filana Therapeutics (FLNA) trades at $0.82, down 6.77% today, amid bearish technical signals but with positive fundamental catalysts. The company shows improving quarterly EPS beats and a favorable EV/EBITDA of 1.03, though it remains unprofitable with negative cash flow. Recent FDA clearance for its epilepsy drug trial has generated optimism, reflected in strong analyst buy ratings (67% consensus).
The outlook balances clinical progress against financial strain. The FDA hold lift on simufilam provides a clear near-term catalyst for Phase 2a trials starting in 2027, supporting the bullish analyst view. However, high cash burn (-$33M net CF in 2025) and lack of revenue pose significant risks to sustainability, requiring careful monitoring of funding and trial milestones.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About TechnipFMC plc Ordinary Share
TechnipFMC is an energy technology company providing subsea systems, surface technologies, and related services across the life of oil and gas fields. Its offerings include equipment, controls, installation support, and digital tools for offshore and onshore projects.
Read more on FTI →
